Cargando…
Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold
BACKGROUND: Common cold is caused by a variety of respiratory viruses. The prevalence in children is high, and it potentially contributes to significant morbidity. Iota-carragenan, a polymer derived from red seaweed, has reduced viral load in nasal secretions and alleviated symptoms in adults with c...
Autores principales: | Fazekas, Tamas, Eickhoff, Philipp, Pruckner, Nathalie, Vollnhofer, Georg, Fischmeister, Gustav, Diakos, Christopher, Rauch, Margit, Verdianz, Maria, Zoubek, Andreas, Gadner, Helmut, Lion, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575307/ https://www.ncbi.nlm.nih.gov/pubmed/22950667 http://dx.doi.org/10.1186/1472-6882-12-147 |
Ejemplares similares
-
Safety and efficacy of iota-carrageenan nasal spray in treatment and prevention of the common cold
por: Bichiri, Diana, et al.
Publicado: (2021) -
Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial
por: Ludwig, Martin, et al.
Publicado: (2013) -
Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial
por: Eccles, R., et al.
Publicado: (2015) -
Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials
por: Koenighofer, Martin, et al.
Publicado: (2014) -
Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis
por: Graf, Christine, et al.
Publicado: (2018)